Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

Alzheimer's and Dementia

Volumn 6, Issue 5, 2010, Pages 378-385

  Mielke, Michelle M ^a   Haughey, Norman J ^a   Ratnam Bandaru, Veera Venkata ^a   Schech, Steven ^a   Carrick, Richard ^a   Carlson, Michelle C ^a,b   Mori, Susumu ^a,c   Miller, Michael I ^d   Ceritoglu, Can ^d   Brown, Timothy ^d   Albert, Marilyn ^a   Lyketsos, Constantine G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Johns Hopkins University   (United States)

Author keywords

Biomarker; Ceramides; Hippocampal volume; Lipids; Mild cognitive impairment; Plasma

Indexed keywords

CERAMIDE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CERAMIDES; COGNITION DISORDERS; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 77956381154     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2010.03.014     Document Type: Article

References (31)

1. R.G. Cutler, J. Kelly, K. Storie, W.A. Pedersen, A. Tammara, and K. Hatanpaa Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease Proc Natl Acad Sci USA 101 2004 2070 2075
2. X. Han, D. M Holtzman, D.W. McKeel Jr., J. Kelley, and J.C. Morris Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis J Neurochem 82 2002 809 818
3. X. He, Y. Huang, B. Li, C.X. Gong, and E.H. Schuchman Deregulation of sphingolipid metabolism in Alzheimer's disease Neurobiol Aging 31 2010 398 408
4. H. Satoi, H. Tomimoto, R. Ohtani, T. Kitano, T. Kondo, and M. Watanabe Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis Neuroscience 130 2005 657 666
5. J.M. Cordy, I. Hussain, C. Dingwall, N.M. Hooper, and A.J. Turner Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein Proc Natl Acad Sci USA 100 2003 11735 11740
6. L. Kalvodova, N. Kahya, P. Schwille, R. Ehehalt, P. Verkade, and D. Drechsel Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro J Biol Chem 280 2005 36815 36823
7. K.S. Vetrivel, H. Cheng, W. Lin, T. Sakurai, T. Li, and N. Nukina Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes J Biol Chem 279 2004 44945 44954
8. L. Puglielli, B.C. Ellis, A.J. Saunders, and D.M. Kovacs Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis J Biol Chem 278 2003 19777 19783
9. A. Jana, and K. Pahan Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease J Biol Chem 279 2004 51451 51459
10. J.T. Lee, J. Xu, J.M. Lee, G. Ku, X. Han, and D.I. Yang Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway J Cell Biol 164 2004 123 131
11. P. Katsel, C. Li, and V. Haroutunian Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? Neurochem Res 32 2007 845 856
12. M.M. Mielke, V.V. Bandaru, N.J. Haughey, P.V. Rabins, C.G. Lyketsos, and M.C. Carlson Serum sphingomyelins and ceramides are early predictors of memory impairment Neurobiol Aging 31 2010 17 24
13. M.M. Mielke, N.A. Kozauer, K.C.G. Chan, M. George, J. Toroney, and M. Zerrate Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease Neuroimage 46 2009 47 55
14. C.P. Hughes, L. Berg, W.L. Danziger, L.A. Coben, and R.L. Martin A new clinical scale for the staging of dementia Br J Psychiatry 140 1982 566 572
15. R.C. Petersen Mild cognitive impairment as a diagnostic entity J Intern Med 256 2004 183 194
16. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease Neurology 34 1984 939 944
17. Alzheimers Association Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators Alzheimer Dis Assoc Disord 18 2004 171 175
18. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
19. R.C. Mohs, D. Knopman, R.C. Petersen, S.H. Ferris, C. Ernesto, and M. Grundman Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study Alzheimer Dis Assoc Disord 11 Suppl 2 1997 S13 S21
20. D.C. Delis, J. Freeland, J.H. Kramer, and E. Kaplan Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test J Consult Clin Psychol 56 1988 123 130
21. D. Wechsler The Wechsler Adult Intelligence Scale-Revised 1988 Psychological Corporation New York, NY
22. R. Reitan Trail Making Test: Manual for Administration, Scoring and Interpretation 1958 Indiana University Medical Center Indianapolis, IN
23. A. Benton, and K. Hamsher Multilingual Aphasia Examination 1976 University of Iowa Iowa City, IA
24. C.R. Jack Jr., M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, and D. Harvey The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods J Magn Reson Imaging 27 2008 685 691
25. J.G. Csernansky, S. Joshi, L. Wang, J.W. Haller, M. Gado, and J.P. Miller Hippocampal morphometry in schizophrenia by high dimensional brain mapping Proc Natl Acad Sci USA 95 1998 11406 11411
26. S. Umeyama Least-squares estimation of transformation parameters between two point patterns IEEE Trans Pattern AnalMach Intell 13 1991 376 380
27. S.C. Joshi, and M.I. Miller Landmark matching via large deformation diffeomorphisms IEEE Trans Image Process 9 2000 1357 1370
28. M.F. Beg, M.I. Miller, A. Trouve, and L. Younes Computing large deformation metric mappings via geodesic flows of diffeomorphisms Int J Comput Vis 61 2005 139 157
29. C.E. Priebe, and D.J. Marchette Alternating kernel and mixture density estimates Comput Stat Data Anal 35 2000 43 65
30. V.V. Bandaru, J.C. McArthur, N. Sacktor, R.G. Cutler, E.L. Knapp, and M.P. Mattson Associative and predictive biomarkers of dementia in HIV-1-infected patients Neurology 68 2007 1481 1487
31. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, and M. Ganguli Global prevalence of dementia: a Delphi consensus study Lancet 366 2005 2112 2117